side effects include:
dyskinesia
hallucinations
somnolence
insomnia
nausea
constipation
diarrhea
dyspepsia
rhinitis
gastrointestinal adverse effects
pergolide
active ingredient
permax
therapy
nausea
patients
continued therapy
diarrhea
dyspepsia
abdominal pain
vomiting
constipation
nervous system
adverse effects
pergolide
active ingredient
permax
therapy
most patients
increase in dyskinesias with pergolide
dizziness
somnolence
patients
insomnia
headache
anxiety
depression
tremor
hallucinations
confusion
patients
receiving pergolide
few patients
following abrupt withdrawal
cases of sleep attacks
patients
receiving pergolide
sleep attacks
number of other patients
receiving dopamine agonists
incidence of hallucinations
patients
experiencing hallucinations during pergolide therapy
dose reduction
expense of control of parkinson
disease
patients
dose beyond the
toxic dose without reoccurrence of hallucinations after a temporary decrease with resolutions of the side effects
hallucinations
following withdrawal of pergolide
several weeks
symptomatic postural hypotension
initial therapy
most patients
effect
low doses
period
weeks
patients
angina in clinical trials
decrease in the dose
possible association between pergolide
active ingredient
permax
development of ventricular arrhythmias
few patients during clinical trials
association
caution
high doses of pergolide
patients with cardiac disease
valvulopathy
pergolide
tricuspid valves
cases
side effect
cessation of pergolide therapy
valve replacement
patients
letter
healthcare professional
eli lilly
company
last february
people
pergolide since the drug
united states
valvulopathy
cardiovascular
side effects
rare reports of pleuritis
pleural effusion
pleural fibrosis
pericarditis
pericardial effusion
cardiac valvulopathy
more valves
retroperitoneal fibrosis
adverse effects
incidence of greater
n =-rrb- among patients
taking pergolide
placebo
postural hypotension
vasodilation
palpitations
orthostatic hypotension
syncope
hypertension
arrhythmia
myocardial infarction
peripheral edema
angina
few patients
dermatologic abnormalities
patients
receiving pergolide
active ingredient
permax
erythema of the lower extremities
erythromelalgia
erythema
hematologic abnormalities
pergolide
active ingredient
permax
therapy
anemia
leukopenia
respiratory adverse effects
dyspnea
nasal congestion
musculoskeletal adverse effects
muscle cramps
arthralgia
myalgias
ocular adverse effects
diplopia
vision changes
patients
pergolide
active ingredient
permax
urinary tract infections
urinary frequency
urinary incontinence
hematuria
pergolide-treated patients
other adverse effects of pergolide
active ingredient
permax
flu-like syndrome
fever
side effects of permax
fda
healthcare professional for medical advice